📰 Peter Ordentlich News
Peter Ordentlich News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Ordentlich. Real-time updates on events, politics, business and more.
June 16, 2023
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) CFO Keith A. Goldan sold 577 shares of the business’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $22.31, for a total value of $12,872.87. Following the transaction, the chief financial officer now owns 2,628 shares of the company’s […]
June 15, 2023
HealthCor Management L.P. lowered its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 91.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 70,000 shares of the company’s stock after selling 789,240 shares during the period. Syndax Pharmaceuticals makes up about […]
June 14, 2023
Eversept Partners LP grew its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 33.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,620,713 shares of the company’s stock after purchasing an additional 409,279 shares during the quarter. Syndax Pharmaceuticals comprises 3.8% of […]
June 13, 2023
Nantahala Capital Management LLC reduced its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 30.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 975,705 shares of the company’s stock after selling 429,723 shares during the period. […]
June 13, 2023
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating)’s stock price traded up 8.6% during trading on Tuesday . The company traded as high as $22.67 and last traded at $22.53. 576,831 shares traded hands during trading, a decline of 32% from the average session volume of 842,487 shares. The stock had previously closed at $20.74. Analyst […]
June 12, 2023
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) Director Briggs Morrison sold 52,855 shares of the stock in a transaction on Friday, June 9th. The stock was sold at an average price of $21.18, for a total value of $1,119,468.90. Following the completion of the transaction, the director now directly owns 17,836 shares of the company’s […]
June 11, 2023
683 Capital Management LLC reduced its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 49.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 570,000 shares of the company’s stock after selling 560,000 shares during the period. Syndax […]
June 7, 2023
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) have earned an average rating of “Moderate Buy” from the eight research firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among […]
June 7, 2023
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating)’s share price was down 3.6% during mid-day trading on Wednesday . The stock traded as low as $20.83 and last traded at $20.92. Approximately 170,399 shares were traded during trading, a decline of 80% from the average daily volume of 844,999 shares. The stock had previously closed at […]
June 1, 2023
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) shares saw unusually-high trading volume on Thursday . Approximately 1,643,856 shares traded hands during trading, an increase of 101% from the previous session’s volume of 819,510 shares.The stock last traded at $20.35 and had previously closed at $19.97. Wall Street Analysts Forecast Growth Several equities research analysts recently […]